Clinical Trials Directory

Trials / Terminated

TerminatedNCT06483113

DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study

Status
Terminated
Phase
Study type
Observational
Enrollment
192 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
7 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifocal) soft contact lens regulatory requirements and standards.

Detailed description

This study includes a Baseline visit and a Year 1 visit. The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a DAILIES TOTAL1 sphere, toric, or multifocal soft contact lens prescription was released. The Baseline visit will be retrospective. All assessments at baseline will be obtained from chart reviews. The Year 1 visit is defined as the visit that occurs 1 year (-2/+4 months) since the Baseline visit during which period the subject is wearing prescribed lenses and a contact lens examination is performed. The Year 1 visit can be either retrospective or prospective in subjects 7 to less than 18 years of age. For subjects 18 years of age and older, the Year 1 visit will be retrospective.

Conditions

Interventions

TypeNameDescription
DEVICEDelefilcon A spherical soft contact lensesSilicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)
DEVICEDelefilcon A toric soft contact lensesSilicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism
DEVICEDelefilcon A multifocal soft contact lensesSilicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia

Timeline

Start date
2024-11-26
Primary completion
2025-02-27
Completion
2025-02-27
First posted
2024-07-03
Last updated
2025-07-20

Locations

12 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06483113. Inclusion in this directory is not an endorsement.